Physician profile
Jade Harris
NPI 1720815988
$465.49
in general payments reported to CMS, 2019-2025
12 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $19.60 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $465.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $82.03 | 2025 | Jardiance, Mounjaro |
| Glaxosmithkline, LLC. | $61.86 | 2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.91 | 2025 | Jardiance |
| Abbott Laboratories | $39.34 | 2025 | Freestyle Libre 3 |
| Abbvie INC. | $35.54 | 2025 | |
| Exact Sciences Corporation | $34.98 | 2024-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $34.43 | 2025 | Airsupra |
| Astellas Pharma US INC | $29.82 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $28.24 | 2025 | |
| Novo Nordisk INC | $27.33 | 2025 | Ozempic |
| Esperion Therapeutics, INC. | $23.08 | 2025 | Nexletol |
| Sanofi Pasteur INC. | $22.93 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jade Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.